5% stakes
Farallon Capital Partners
Institution
- 5% stake reports
- 32
- 5% stake stocks
- 16
- Latest report
- 26/05/29
5% stake reports
| Stock | ||
|---|---|---|
| BridgeBio Pharma BBIO05/29 | 5.2%10,226,063 sh | First report |
| InflaRx IFRX05/14 | 5.1%7,500,000 sh | First report |
| Tyra Biosciences TYRA05/12 | 6.6%3,580,818 sh | +1.0pp |
| Beta Bionics BBNX05/12 | 8.1%3,607,920 sh | −1.8pp |
| Grail GRAL05/11 | 7.8%3,253,684 sh | +1.9pp |
| Tango Therapeutics TNGX05/11 | 7.8%11,257,203 sh | −1.9pp |
| Tyra Biosciences TYRA02/20 | 5.6%2,984,818 sh | First report |
| Agios Pharmaceuticals AGIO02/09 | 8.8%5,159,505 sh | −1.1pp |
| Lantheus Holdings LNTH02/05 | 8.2%5,427,479 sh | +3.1pp |
| Savara SVRA02/05 | 6.9%15,000,000 sh | −3.1pp |
| Exelixis EXEL01/05 | 5.9%15,709,500 sh | −0.9pp |
| Minerva Neurosciences NERV25/12/29 | 9.99%4,539,854 sh | First report |
| Grail GRAL25/11/24 | 5.5%2,179,684 sh | +0.6pp |
| Grail GRAL25/11/13 | 4.9%1,947,684 sh | First report |
| Lantheus Holdings LNTH25/11/12 | 5.1%3,477,227 sh | −3.7pp |
| Tango Therapeutics TNGX25/11/12 | 9.7%10,757,000 sh | +1.3pp |
| Liquidia LQDA25/11/12 | 9.95%8,565,638 sh | +1.9pp |
| Assembly Biosciences ASMB25/08/15 | 7.3%1,140,510 sh | First report |
| Tango Therapeutics TNGX25/08/13 | 8.4%9,157,000 sh | +1.8pp |
| New York Times NYT25/08/12 | 3.5%5,609,546 sh | −2.0pp |
